CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19
Saeedeh Ebrahimi, Hashem Khanbabaei, Samaneh Abbasi, Mona Fani, Saber Soltani, Milad Zandi, Zahra Najafimemar
Abstract
More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.
Topics & Concepts
CRISPRPandemicCoronavirus disease 2019 (COVID-19)Diagnostic testSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakIntensive care medicineDiseaseVirologyCoronavirusMedicineBiologyInfectious disease (medical specialty)PathologyPediatricsGeneticsOutbreakGeneCRISPR and Genetic EngineeringSARS-CoV-2 and COVID-19 ResearchMosquito-borne diseases and control